Selma Tobudic

机构：Medical University of Vienna · ORCID：0000-0002-8241-8317

发表论文 104 篇 · 总被引 2479 次 · h-index 27

代表论文

• SARS-CoV-2-mRNA Booster Vaccination Reverses Non-Responsiveness and Early Antibody Waning in Immunocompromised Patients – A Phase Four Study Comparing Immune Responses in Patients With Solid Cancers, Multiple Myeloma and Inflammatory Bowel Disease (2022 · Frontiers in Immunology · 被引 64)
• Safety and immunogenicity of a third COVID-19 vaccination in patients with immune-mediated inflammatory diseases compared with healthy controls (2022 · Annals of the Rheumatic Diseases · 被引 43)
• Heterologous vector versus homologous mRNA COVID-19 booster vaccination in non-seroconverted immunosuppressed patients: a randomized controlled trial (2022 · Nature Communications · 被引 34)
• Antimicrobial potential and osteoblastic cell growth on electrochemically modified titanium surfaces with nanotubes and selenium or silver incorporation (2022 · Scientific Reports · 被引 15)
• Reactogenicity and immunogenicity of the second COVID-19 vaccination in patients with inborn errors of immunity or mannan-binding lectin deficiency (2022 · Frontiers in Immunology · 被引 13)
• The accelerated waning of immunity and reduced effect of booster in patients treated with bDMARD and tsDMARD after SARS-CoV-2 mRNA vaccination (2023 · Frontiers in Medicine · 被引 8)